Carotid endarterectomy at the millennium: What interventional therapy must match

Annals of Surgery

Volumn 240, Issue 3, 2004, Pages 535-546

  LaMuraglia, Glenn M ^a,b   Brewster, David C ^a   Moncure, Ashby C ^a   Dorer, David J ^b   Stoner, Michael C ^a   Trehan, Samir K ^a   Drummond, Elizabeth C ^a   Abbott, William M ^a   Cambria, Richard P ^a   Freischlag, Julie Ann ^c   Rich, Norman M ^c   Zarins, Christopher K ^c  

^a General Surgical Services   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c Massachusetts General Hospital ^*

Author keywords

[No Author keywords available]

Indexed keywords

CAROTID ARTERY OBSTRUCTION; CAROTID ENDARTERECTOMY; CONFERENCE PAPER; FEMALE; FOLLOW UP; HEALTH CARE UTILIZATION; HUMAN; KAPLAN MEIER METHOD; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RESOURCE MANAGEMENT; RESTENOSIS; RISK ASSESSMENT; STROKE; SURGICAL RISK; SURVIVAL TIME;

AGED; ANGIOPLASTY, BALLOON; CAROTID STENOSIS; CEREBROVASCULAR ACCIDENT; ENDARTERECTOMY, CAROTID; FEMALE; HUMANS; MALE; RISK FACTORS; STENTS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 4344642730     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.sla.0000137142.26925.3c     Document Type: Conference Paper

References (57)

1. North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med. 1991;325:445-453.
2. Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). Lancet. 1998;351:1379-1387.
3. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. Endarterectomy for asymptomatic carotid artery stenosis. JAMA. 1995;273:1421-1428.
4. Moore WS, Barnett HJ, Beebe HG, et al. Guidelines for carotid endarterectomy: a multidisciplinary consensus statement from the Ad Hoc Committee, American Heart Association. Circulation. 1995;91:566-579.
5. Anthony T, Johansen K. Optimal outcome for "high-risk" carotid endarterectomy. Am J Surg. 1994;167:469-471.
6. Domenig C, Hamdan AD, Belfield AK, et al. Recurrent stenosis and contralateral occlusion: high-risk situations in carotid endarterectomy? Ann Vasc Surg. 2003;17:622-628.
7. Gasparis AP, Ricotta L, Cuadra SA, et al. High-risk carotid endarterectomy: fact or fiction. J Vasc Surg. 2003;37:40-46.
8. Dangas G, Laird JR Jr. , Mehran R, et al. Carotid artery stenting in patients with high-risk anatomy for carotid endarterectomy. J Endovasc Ther. 2001;8:39-43.
9. Raby KE, Brull SJ, Timimi F, et al. The effect of heart rate control on myocardial ischemia among high-risk patients after vascular surgery. Anesth Analg. 1999;88:477-482.
10. Robless P, Emson M, Thomas D, et al. Are we detecting and operating on high risk patients in the asymptomatic carotid surgery trial? the Asymptomatic Carotid Surgery Trial Collaborators. Eur J Vasc Endovasc Surg. 1998:16:59-64.
11. Reed AB, Gaccione P, Belkin M, et al. Preoperative risk factors for carotid endarterectomy: defining the patient at high risk. J Vasc Surg. 2003;37:1191-1199.
12. Shawl F, Kadro W, Domanski MJ, et al. Safety and efficacy of elective carotid artery stenting in high-risk patients. J Am Coll Cardiol. 2000; 35:1721-1728.
13. Mericle RA, Kim SH, Lanzino G, et al. Carotid artery angioplasty and use of stents in high-risk patients with contralateral occlusions. J Neurosurg. 1999;90:1031-1036.
14. Malek AM, Higashida RT, Phatouros CC, et al. Stent angioplasty for cervical carotid artery stenosis in high-risk symptomatic NASCET-ineligible patients. Stroke. 2000;31:3029-3033.
15. Lucertini G. Carotid angioplasty with stenting and carotid endarterectomy for high-risk patients. Stroke 2003;34:e42-3.
16. Jordan WD Jr, Alcocer F, Wirthlin DJ, et al. High-risk carotid endarterectomy: challenges for carotid stent protocols. J Vasc Surg. 2002;35: 16-21.
17. Ouriel K, Hertzer NR, Beven EG, et al. Preprocedural risk stratification: identifying an appropriate population for carotid stenting. J Vasc Surg. 2001;33:728-732.
18. Archie JP Jr. A fifteen-year experience with carotid endarterectomy after a formal operative protocol requiring highly frequent patch angioplasty. J Vasc Surg. 2000;31:724-735.
19. Rockman CB, Jacobowitz GR, Adelman MA, et al. The benefits of carotid endarterectomy in the octogenarian: a challenge to the results of carotid angioplasty and stenting. Ann Vasc Surg. 2003;17:9-14.
20. Chang JB, Stein TA. Ten-year outcome after saphenous vein patch angioplasty in males and females after carotid endarterectomy. Vasc Endovascular Surg. 2002;36:21-27.
21. Bowser AN, Bandyk DF, Evans A, et al. Outcome of carotid stent-assisted angioplasty versus open surgical repair of recurrent carotid stenosis. J Vasc Surg. 2003;38:432-438.
22. Wholey MH, Al-Mubarek N. Updated review of the global carotid artery stent registry. Catheter Cardiovasc Interv. 2003;60:259-266.
23. Paniagua D, Howell M, Strickman N, et al. Outcomes following extracranial carotid artery stenting in high-risk patients. J Invasive Cardiol. 2001;13:375-381.
24. Hobson RW 2nd, Lal BK, Chakhtoura E, et al. Carotid artery stenting: analysis of data for 105 patients at high risk. J Vasc Surg. 2003;37: 1234-1239.
25. Roubin GS, New G, Iyer SS, et al. Immediate and late clinical outcomes of carotid artery stenting in patients with symptomatic and asymptomatic carotid artery stenosis: a 5-year prospective analysis. Circulation. 2001; 103:532-537.
26. Endovascular versus surgical treatment in patients with carotid stenosis in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): a randomised trial. Lancet. 2001;357:1729-1737.
27. Carotid revascularization using endarterectomy or stenting systems (CARESS): phase I clinical trial. J Endovasc Ther. 2003;10:1021-1030.
28. Becquemin JP, Ben El Kadi H, Desgranges P, et al. Carotid stenting versus carotid surgery: a prospective cohort study. J Endovasc Ther. 2003; 10:687-694.
29. Yadav JS. Carotid stenting in high-risk patients: design and rationale of the SAPPHIRE trial. Cleve Clin J Med. 2004;71(suppl 1):S45-46.
30. Yadav J. Thirty day results of the stenting and angioplasty with protection in patients at high risk for endarterectomy (SAPPHIRE) trial. Presented at 75th scientific sessions of the American Heart Association 2003.
31. Williams GR, Jiang JG, Matchar DB, et al. Incidence and occurrence of total (first-ever and recurrent) stroke. Stroke. 1999;30:2523-2528.
32. Baker JD, Rutherford RB, Bernstein EF, et al. Suggested standards for reports dealing with cerebrovascular disease: Subcommittee on Reporting Standards for Cerebrovascular Disease, Ad Hoc Committee on Reporting Standards, Society for Vascular Surgery/North American Chapter, International Society for Cardiovascular Surgery. J Vasc Surg. 1988;8:721-729.
33. Call GK, Abbott WM, Macdonald NR, et al. Correlation of continuous-wave Doppler spectral flow analysis with gross pathology in carotid stenosis. Stroke. 1988;19:584-588.
34. Hamdan AD, Pomposelli FB Jr, Gibbons GW, et al. Perioperative strokes after 1001 consecutive carotid endarterectomy procedures without an electroencephalogram: incidence, mechanism, and recovery. Arch Surg. 1999;134:412-415.
35. Carballo RE, Towne JB, Seabrook GR, et al. An outcome analysis of carotid endarterectomy: the incidence and natural history of recurrent stenosis. J Vasc Surg. 1996;23:749-753.
36. Hertzer NR, O'Hara PJ, Mascha EJ, et al. Early outcome assessment for 2228 consecutive carotid endarterectomy procedures: the Cleveland Clinic experience from 1989 to 1995. J Vasc Surg. 1997;26:1-10.
37. Engelter S, Lyrer P. Antiplatelet therapy for preventing stroke and other vascular events after carotid endarterectomy. Cochrane Database Syst Rev. 2003:CD001458.
38. Fearn SJ, Parry AD, Picton AJ, et al. Should heparin be reversed after carotid endarterectomy? A randomised prospective trial. Eur J Vasc Endovasc Surg. 1997;13:394-397.
39. Hill BB, Olcott CT, Dalman RL, et al. Reoperation for carotid stenosis is as safe as primary carotid endarterectomy. J Vasc Surg. 1999;30:26-35.
40. Hertzer NR, Feldman BJ, Beven EG, et al. A prospective study of the incidence of injury to the cranial nerves during carotid endarterectomy. Surg Gynecol Obstet. 1980;151:781-784.
41. AbuRahma AF, Choueiri MA. Cranial and cervical nerve injuries after repeat carotid endarterectomy. J Vasc Surg. 2000;32:649-654.
42. Kresowik TF, Bratzler D, Karp HR, et al. Multistate utilization, processes, and outcomes of carotid endarterectomy. J Vasc Surg. 2001;33: 227-234.
43. Ecker RD, Pichelmann MA, Meissner I, et al. Durability of carotid endarterectomy. Stroke. 2003;34:2941-2944.
44. Hobson RW 2nd, Weiss DG, Fields WS, et al. Efficacy of carotid endarterectomy for asymptomatic carotid stenosis: the Veterans Affairs Cooperative Study Group. N Engl J Med. 1993;328:221-227.
45. Long-term effectiveness and safety of pravastatin in 9014 patients with coronary heart disease and average cholesterol concentrations: the LIPID trial follow-up. Lancet. 2002;359:1379-1387.
46. Ricotta JJ, Wall LP. Treatment of patients with combined coronary and carotid atherosclerosis. J Cardiovasc Surg (Torino). 2003;44:363-369.
47. Collins R, Armitage J, Parish S, et al. Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions. Lancet. 2004;363:757-767.
48. Maleux G, Bemaerts P, Thijs V, et al. Extracranial carotid artery stenting in surgically high-risk patients using the carotid wallstent endoprosthesis: midterm clinical and ultrasound follow-up results. Cardiovasc Intervent Radiol. 2003;26:3.
49. Zee RY, Fernandez-Otiz A, Macaya C, et al. Lipid metabolism and occurrence of post-percutaneous transluminal coronary angioplasty restenosis: role of cholesteryl ester transfer protein and paraoxonase/arylesterase. J Thromb Haemost. 2003;1:1202-1207.
50. Rapp JH, Qvarfordt P, Krupski WC, et al. Hypercholesterolemia and early restenosis after carotid endarterectomy. Surgery. 1987;101:277-282.
51. Cuming R, Worrell P, Woolcock NE, et al. The influence of smoking and lipids on restenosis after carotid endarterectomy. Eur J Vasc Surg. 1993;7:572-576.
52. Collier PE. Do clinical pathways for major vascular surgery improve outcomes and reduce cost? J Vasc Surg. 1997;26:179-185.
53. Kilaru S, Korn P, Kasirajan K, et al. Is carotid angioplasty and stenting more cost effective than carotid endarterectomy? J Vasc Surg. 2003;37: 331-339.
54. Birkmeyer JD, Finlayson EV, Birkmeyer CM. Volume standards for high-risk surgical procedures: potential benefits of the Leapfrog initiative. Surgery. 2001;130:415-422.
55. Samsa G, Oddone EZ, Horner R, et al. To what extent should quality of care decisions be based on health outcomes data? application to carotid endarterectomy. Stroke. 2002;33:2944-2949.
56. Peck C, Peck J, Peck A. Comparison of carotid endarterectomy at high- and low-volume hospitals. Am J Surg. 2001;181:450-453.
57. Hannan EL, Popp AJ, Feustel P, et al. Association of surgical specialty and processes of care with patient outcomes for carotid endarterectomy. Stroke. 2001;32:2890-2897.